Related Experiment Video
Updated: Sep 6, 2025
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
17.7K
Recommendations on Off-Label Drug Use in Pediatric Guidelines
Min Meng1,2,3,4, Qi Zhou5,6, Wenjuan Lei4
1Department of Chevidence Lab Child & Adolescent Health, Children's Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in Pharmacology
|June 27, 2022
Summary
Pediatric guidelines often lack sufficient evidence for off-label drug use recommendations, potentially exposing children to medical risks. This analysis reveals gaps in supporting data and reporting for these crucial drug use decisions.
Area of Science:
- Pediatric pharmacology
- Clinical guideline analysis
- Evidence-based medicine
Background:
- Off-label drug use in children is common but often lacks robust evidence.
- Pediatric clinical practice guidelines are essential for guiding safe and effective medication use.
- Systematic analysis of evidence supporting off-label drug recommendations in these guidelines is needed.
Purpose of the Study:
- To systematically analyze the supporting evidence, drug information, and types of off-label drug use in pediatric guidelines.
- To identify gaps in evidence and reporting for off-label medication recommendations in pediatric care.
Main Methods:
- A systematic cross-sectional study of pediatric clinical practice guidelines published between 2018-2020.
- Searched MEDLINE (via PubMed) and Embase databases for relevant literature.
- Descriptive analysis of guideline sources, evidence grading, types of off-label use, and cited references.
Main Results:
- 66 pediatric guidelines with 605 recommendations were analyzed; 14.4% lacked references.
- Commonly cited studies included pediatric RCTs (14.0%), case series (11.6%), and reviews (11.4%), with 21% of references being adult studies.
- Many recommendations, even strong ones, were supported by low-level evidence (C or D).
- Unapproved populations (48.8%) were the most common type of off-label drug use addressed.
Conclusions:
- Significant gaps exist in the evidence base and reporting for off-label drug use recommendations in pediatric guidelines.
- Inadequate evidence supporting off-label drug use in children may lead to medical risks.
- Improved reporting and stronger evidence are crucial for safer pediatric medication practices.
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
842
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
842
01:21Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
01:25Drug Classes and Categories
2.2K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.2K
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
01:17Drug Nomenclature
2.2K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.2K
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K